UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

FAK in cancer: mechanistic findings and clinical applications

Nature reviews. Cancer, 2014-09, Vol.14 (9), p.598-610

2014

Volltextzugriff (PDF)

RSK Isoforms in Cancer Cell Invasion and Metastasis

Cancer research (Chicago, Ill.), 2013-10, Vol.73 (20), p.6099-6105

2013

Volltextzugriff (PDF)

Englerin a selectively induces necrosis in human renal cancer cells

PloS one, 2012-10, Vol.7 (10), p.e48032

2012

Volltextzugriff (PDF)

FAK Inhibition disrupts a β5 integrin signaling axis controlling anchorage-independent ovarian carcinoma growth

Molecular cancer therapeutics, 2014-08, Vol.13 (8), p.2050-2061

2014

Volltextzugriff (PDF)

RSK2 Protein Suppresses Integrin Activation and Fibronectin Matrix Assembly and Promotes Cell Migration

The Journal of biological chemistry, 2012-12, Vol.287 (52), p.43424-43437

2012

Volltextzugriff (PDF)

RSK2 activity mediates glioblastoma invasiveness and is a potential target for new therapeutics

Oncotarget, 2016-11, Vol.7 (48), p.79869-79884

2016

Volltextzugriff (PDF)

Neopetrocyclamines A and B, Polycyclic Diamine Alkaloids from the Sponge Neopetrosia cf exigua

Journal of natural products (Washington, D.C.), 2015-03, Vol.78 (3), p.543-547

2015

Volltextzugriff (PDF)

INBRX-120, a CD8α-targeted detuned IL-2 that selectively expands and activates tumoricidal effector cells for safe and durable in vivo responses

Journal for immunotherapy of cancer, 2023-01, Vol.11 (1), p.e006116

2023

Volltextzugriff (PDF)

Oxidized LDL induces FAK-dependent RSK signaling to drive NF-κB activation and VCAM-1 expression

Journal of cell science, 2016-04, Vol.129 (8), p.1580-1591

2016

Volltextzugriff (PDF)

Organometallic Titanocene–Gold Compounds as Potential Chemotherapeutics in Renal Cancer. Study of their Protein Kinase Inhibitory Properties

Organometallics, 2014-11, Vol.33 (22), p.6669-6681

2014

Volltextzugriff (PDF)

Stictamides A−C, MMP12 Inhibitors Containing 4-Amino-3-hydroxy-5-phenylpentanoic Acid Subunits

Journal of organic chemistry, 2011-05, Vol.76 (10), p.3635-3643

2011

Volltextzugriff (PDF)

Analyses of merlin/NF2 connection to FAK inhibitor responsiveness in serous ovarian cancer

Gynecologic oncology, 2014-07, Vol.134 (1), p.104-111

2014

Volltextzugriff (PDF)

Synthesis of a stable and orally bioavailable englerin analogue

Bioorganic & medicinal chemistry letters, 2016-06, Vol.26 (11), p.2641-2644

2016

Volltextzugriff (PDF)

Phosphorylation is the switch that turns PEA-15 from tumor suppressor to tumor promoter

Small GTPases, 2012-07, Vol.3 (3), p.173-177

2012

Volltextzugriff (PDF)

PEA15 impairs cell migration and correlates with clinical features predicting good prognosis in neuroblastoma

International journal of cancer, 2012-10, Vol.131 (7), p.1556-1568

2012

Volltextzugriff (PDF)

High dose of dietary resveratrol enhances insulin sensitivity in healthy rats but does not lead to metabolite concentrations effective for SIRT1 expression

Molecular nutrition & food research, 2011-08, Vol.55 (8), p.1197-1206

2011

Volltextzugriff (PDF)

The death effector domain protein PEA‐15 negatively regulates T‐cell receptor signaling

The FASEB journal, 2010-08, Vol.24 (8), p.2818-2828

2010

Volltextzugriff (PDF)

Abstract A61: FAK activity sustains intrinsic and acquired ovarian cancer resistance to platinum chemotherapy

Clinical cancer research, 2020-07, Vol.26 (13_Supplement), p.A61-A61

2020

Volltextzugriff (PDF)

PEA-15 potentiates H-Ras-mediated epithelial cell transformation through phospholipase D

Oncogene, 2012-07, Vol.31 (30), p.3547-3560

2012

Volltextzugriff (PDF)

Bit-1 Mediates Integrin-dependent Cell Survival through Activation of the NFκB Pathway

The Journal of biological chemistry, 2011-04, Vol.286 (16), p.14713-14723

2011

Volltextzugriff (PDF)

Abstract 3513: INBRX-121, a safe and efficacious molecular targeted cytokine that enhances NK cell-mediated tumor killing

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.3513-3513

2022

Volltextzugriff (PDF)

Abstract NTOC-106: FAK INHIBITION RE–SENSITIZES PLATINUM–RESISTANT SEROUS OVARIAN CANCER

Clinical cancer research, 2017-06, Vol.23 (11_Supplement), p.NTOC-106-NTOC-106

2017

Volltextzugriff (PDF)

Abstract 1991: Vulnerability of platinum-resistant ovarian cancer to FAK inhibition

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.1991-1991

2018

Volltextzugriff (PDF)

Abstract 3812: FAK inhibition resensitizes platinum-resistant serous ovarian cancer

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.3812-3812

2016

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(28)

Sprache

Englisch
(28)

Erscheinungsjahr

n.n

Thema

Humans
(19)
Science & Technology
(19)
Animals
(17)
Life Sciences & Biomedicine
(16)
Mice
(9)
Oncology
(8)
Signal Transduction
(8)
Cell Line, Tumor
(7)
Apoptosis
(6)
Cancer
(6)
Cell Biology
(6)
Antineoplastic Agents - Pharmacology
(5)
Focal Adhesion Kinase 1 - Metabolism
(5)
Biochemistry & Molecular Biology
(4)
Biology
(4)
Cell Adhesion
(4)
Female
(4)
Neoplasm Invasiveness
(4)
Ribosomal Protein S6 Kinases, 90-Kda - Metabolism
(4)
Tumors
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

FAK in cancer: mechanistic findings and clinical applications

RSK Isoforms in Cancer Cell Invasion and Metastasis

FAK activity sustains intrinsic and acquired ovarian cancer resistance to platinum chemotherapy

Englerin a selectively induces necrosis in human renal cancer cells

FAK Inhibition disrupts a β5 integrin signaling axis controlling anchorage-independent ovarian carcinoma growth

RSK2 Protein Suppresses Integrin Activation and Fibronectin Matrix Assembly and Promotes Cell Migration

RSK2 activity mediates glioblastoma invasiveness and is a potential target for new therapeutics

Neopetrocyclamines A and B, Polycyclic Diamine Alkaloids from the Sponge Neopetrosia cf exigua

INBRX-120, a CD8α-targeted detuned IL-2 that selectively expands and activates tumoricidal effector cells for safe and durable in vivo responses

Oxidized LDL induces FAK-dependent RSK signaling to drive NF-κB activation and VCAM-1 expression

Organometallic Titanocene–Gold Compounds as Potential Chemotherapeutics in Renal Cancer. Study of their Protein Kinase Inhibitory Properties

Stictamides A−C, MMP12 Inhibitors Containing 4-Amino-3-hydroxy-5-phenylpentanoic Acid Subunits

Analyses of merlin/NF2 connection to FAK inhibitor responsiveness in serous ovarian cancer

Synthesis of a stable and orally bioavailable englerin analogue

Phosphorylation is the switch that turns PEA-15 from tumor suppressor to tumor promoter

PEA15 impairs cell migration and correlates with clinical features predicting good prognosis in neuroblastoma

High dose of dietary resveratrol enhances insulin sensitivity in healthy rats but does not lead to metabolite concentrations effective for SIRT1 expression

The death effector domain protein PEA‐15 negatively regulates T‐cell receptor signaling

Abstract A61: FAK activity sustains intrinsic and acquired ovarian cancer resistance to platinum chemotherapy

PEA-15 potentiates H-Ras-mediated epithelial cell transformation through phospholipase D

Bit-1 Mediates Integrin-dependent Cell Survival through Activation of the NFκB Pathway

Abstract 3513: INBRX-121, a safe and efficacious molecular targeted cytokine that enhances NK cell-mediated tumor killing

Abstract NTOC-106: FAK INHIBITION RE–SENSITIZES PLATINUM–RESISTANT SEROUS OVARIAN CANCER

Abstract 1991: Vulnerability of platinum-resistant ovarian cancer to FAK inhibition

Abstract 3812: FAK inhibition resensitizes platinum-resistant serous ovarian cancer

Suchergebnisse filtern